Cargando…
Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models.
This study reports on the development of a liposomal formulation of vincristine with significantly enhanced stability and biological properties. The in vitro and in vivo pharmacokinetic, tumour delivery and efficacy properties of liposomal vincristine formulations based on sphingomyelin (SM) and cho...
Autores principales: | Webb, M. S., Harasym, T. O., Masin, D., Bally, M. B., Mayer, L. D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034038/ https://www.ncbi.nlm.nih.gov/pubmed/7547237 |
Ejemplares similares
-
Pharmacology of liposomal vincristine in mice bearing L1210 ascitic and B16/BL6 solid tumours.
por: Mayer, L. D., et al.
Publicado: (1995) -
Marqibo(®) (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine
por: Silverman, Jeffrey A., et al.
Publicado: (2012) -
The influence of different long-circulating materials on the pharmacokinetics of liposomal vincristine sulfate
por: Zhang, Jing, et al.
Publicado: (2016) -
Pharmacokinetic Behavior of Vincristine and Safety Following Intravenous Administration of Vincristine Sulfate Liposome Injection in Chinese Patients With Malignant Lymphoma
por: Yang, Fen, et al.
Publicado: (2018) -
Vincristine liposomes with smaller particle size have stronger diffusion ability in tumor and improve tumor accumulation of vincristine significantly
por: Ma, Siyu, et al.
Publicado: (2017)